×
About 42,976 results

ALLMedicine™ Ulcerative Colitis Center

Research & Reviews  20,173 results

Corrigendum: Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colit...
https://doi.org/10.5009/gnl15011
Gut and Liver; Moon JR, Lee CK et. al.

Jan 14th, 2021 - Corrigendum: Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea.|2021|Moon JR,Lee CK,Hong SN,Im JP,Ye BD,|

Long-Term Efficacy And Safety Of Ozanimod In Moderate-To-Severe Ulcerative Colitis: Res...
https://doi.org/10.1093/ecco-jcc/jjab012
Journal of Crohn's & Colitis; Sandborn WJ, Feagan BG et. al.

Jan 13th, 2021 - This analysis examined long-term safety and efficacy of ozanimod in patients with moderate-to-severe UC with ≥4 years of follow-up in the phase 2 TOUCHSTONE open-label extension (OLE). Patients receiving placebo or ozanimod HCl 0.5 mg or 1 mg duri...

Hecogenin and fluticasone combination attenuates TNBS-induced ulcerative colitis in rat...
https://doi.org/10.1080/08923973.2021.1872617
Immunopharmacology and Immunotoxicology; Ingawale DK, Mandlik SK et. al.

Jan 13th, 2021 - Ulcerative colitis is common types of severe, progressive, idiopathic inflammatory bowel disease that involves the mucosal lining of the large intestine. The purpose of the study is to explore the effects of hecogenin in TNBS (2, 4, 6- trinitroben...

A semi-tryptic peptide centric metaproteomic mining approach and its potential utility ...
https://doi.org/10.1186/s40168-020-00967-x 10.1146/annurev-biochem-062917-012848 10.1111/1574-6976.12050 10.1038/s41467-018-07228-4 10.1074/jbc.M808686200 10.1021/acssynbio.9b00358 10.1016/j.devcel.2015.08.009 10.1126/science.1061315 10.1016/S0022-2836(03)00922-7 10.1038/s41564-018-0306-4 10.1038/s41586-019-1237-9 10.1038/nmicrobiol.2017.4 10.1038/s41564-017-0089-z 10.1186/s40168-019-0618-5 10.1021/ac303053e 10.1186/s40168-019-0631-8 10.1186/s40168-017-0290-6 10.1186/s40168-016-0176-z 10.1038/s41467-018-05357-4 10.1021/pr300955f 10.1038/s41467-019-10513-5 10.1038/nbt.3418 10.1038/nbt.2942 10.1038/nature17645 10.1038/s41587-018-0008-8 10.1093/bioinformatics/btq461 10.1074/mcp.M111.010587 10.1038/nbt.1511 10.1038/nbt.4236 10.1021/pr101065j 10.1021/ac9016693 10.1021/pr300576s 10.1021/acs.jproteome.8b00716 10.1016/S0006-291X(67)80055-X 10.1101/gr.849004 10.1093/nar/gky310 10.1093/nar/gkx295 10.1371/journal.pone.0027173 10.1186/s12864-016-2855-3 10.1016/j.cels.2018.08.009 10.1074/mcp.M115.055103 10.1038/nature15377 10.1002/jcp.1041500323 10.1002/pmic.201400560 10.1128/AEM.66.12.5128-5133.2000 10.1128/AEM.68.6.2809-2813.2002 10.1128/JB.06737-11 10.1016/j.crohns.2008.06.001 10.1016/S0140-6736(16)32126-2 10.1136/gutjnl-2015-309147 10.1136/gutjnl-2011-300775 10.1371/journal.pone.0066074 10.1186/s40168-018-0604-3 10.1136/gutjnl-2018-317571 10.1126/scitranslmed.aaf9655
Microbiome Yan Z, He F et. al.

Jan 13th, 2021 - Proteolysis regulation allows gut microbes to respond rapidly to dynamic intestinal environments by fast degradation of misfolded proteins and activation of regulatory proteins. However, alterations of gut microbial proteolytic signatures under co...

see more →

Guidelines  87 results

Spatialization in working memory: can individuals reverse the cultural direction of the...
https://doi.org/10.1016/j.gastrohep.2020.05.009
Annals of the New York Academy of Sciences References; Muñoz F, Ripollés T et. al.

Sep 26th, 2020 - Ultrasound has an excellent diagnostic performance when Crohn's disease is suspected, when performing an activity assessment, or determining the extension and location of Crohn's disease, very similar to other examinations such as MRI or CT. It ha...

Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcera...
https://doi.org/10.1053/j.gastro.2020.03.011
Gastroenterology

Mar 28th, 2020 - Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.|2020| ,|

Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.
https://doi.org/10.1053/j.gastro.2020.03.012
Gastroenterology Feuerstein JD, Isaacs KL et. al.

Mar 14th, 2020 - Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Col...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175923
Gastroenterology Feuerstein JD, Isaacs KL et. al.

Jan 16th, 2020 - AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|therapeutic use,standards,diagnosis,immunology,therapy,diagnostic imaging,immunology,p...

Management of ulcerative colitis: summary of updated NICE guidance.
https://doi.org/10.1136/bmj.l5897
BMJ (Clinical Research Ed.); Abdulrazeg O, Li B et. al.

Oct 29th, 2019 - Management of ulcerative colitis: summary of updated NICE guidance.|2019|Abdulrazeg O,Li B,Epstein J, ,|drug therapy,methods,therapeutic use,drug therapy,drug therapy,

see more →

Drugs  283 results see all →

Clinicaltrials.gov  21,231 results

Corrigendum: Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colit...
https://doi.org/10.5009/gnl15011
Gut and Liver; Moon JR, Lee CK et. al.

Jan 14th, 2021 - Corrigendum: Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea.|2021|Moon JR,Lee CK,Hong SN,Im JP,Ye BD,|

Long-Term Efficacy And Safety Of Ozanimod In Moderate-To-Severe Ulcerative Colitis: Res...
https://doi.org/10.1093/ecco-jcc/jjab012
Journal of Crohn's & Colitis; Sandborn WJ, Feagan BG et. al.

Jan 13th, 2021 - This analysis examined long-term safety and efficacy of ozanimod in patients with moderate-to-severe UC with ≥4 years of follow-up in the phase 2 TOUCHSTONE open-label extension (OLE). Patients receiving placebo or ozanimod HCl 0.5 mg or 1 mg duri...

Hecogenin and fluticasone combination attenuates TNBS-induced ulcerative colitis in rat...
https://doi.org/10.1080/08923973.2021.1872617
Immunopharmacology and Immunotoxicology; Ingawale DK, Mandlik SK et. al.

Jan 13th, 2021 - Ulcerative colitis is common types of severe, progressive, idiopathic inflammatory bowel disease that involves the mucosal lining of the large intestine. The purpose of the study is to explore the effects of hecogenin in TNBS (2, 4, 6- trinitroben...

A semi-tryptic peptide centric metaproteomic mining approach and its potential utility ...
https://doi.org/10.1186/s40168-020-00967-x 10.1146/annurev-biochem-062917-012848 10.1111/1574-6976.12050 10.1038/s41467-018-07228-4 10.1074/jbc.M808686200 10.1021/acssynbio.9b00358 10.1016/j.devcel.2015.08.009 10.1126/science.1061315 10.1016/S0022-2836(03)00922-7 10.1038/s41564-018-0306-4 10.1038/s41586-019-1237-9 10.1038/nmicrobiol.2017.4 10.1038/s41564-017-0089-z 10.1186/s40168-019-0618-5 10.1021/ac303053e 10.1186/s40168-019-0631-8 10.1186/s40168-017-0290-6 10.1186/s40168-016-0176-z 10.1038/s41467-018-05357-4 10.1021/pr300955f 10.1038/s41467-019-10513-5 10.1038/nbt.3418 10.1038/nbt.2942 10.1038/nature17645 10.1038/s41587-018-0008-8 10.1093/bioinformatics/btq461 10.1074/mcp.M111.010587 10.1038/nbt.1511 10.1038/nbt.4236 10.1021/pr101065j 10.1021/ac9016693 10.1021/pr300576s 10.1021/acs.jproteome.8b00716 10.1016/S0006-291X(67)80055-X 10.1101/gr.849004 10.1093/nar/gky310 10.1093/nar/gkx295 10.1371/journal.pone.0027173 10.1186/s12864-016-2855-3 10.1016/j.cels.2018.08.009 10.1074/mcp.M115.055103 10.1038/nature15377 10.1002/jcp.1041500323 10.1002/pmic.201400560 10.1128/AEM.66.12.5128-5133.2000 10.1128/AEM.68.6.2809-2813.2002 10.1128/JB.06737-11 10.1016/j.crohns.2008.06.001 10.1016/S0140-6736(16)32126-2 10.1136/gutjnl-2015-309147 10.1136/gutjnl-2011-300775 10.1371/journal.pone.0066074 10.1186/s40168-018-0604-3 10.1136/gutjnl-2018-317571 10.1126/scitranslmed.aaf9655
Microbiome Yan Z, He F et. al.

Jan 13th, 2021 - Proteolysis regulation allows gut microbes to respond rapidly to dynamic intestinal environments by fast degradation of misfolded proteins and activation of regulatory proteins. However, alterations of gut microbial proteolytic signatures under co...

see more →

News  1,143 results

Ulcerative Colitis: Persistence and Colectomy-free Survival With Golimumab vs Adalimumab
https://www.medscape.com/viewarticle/941486

Nov 23rd, 2020 - Takeaway The persistence rates of antitumour necrosis factor agents golimumab and adalimumab as first-line or second-line biologic therapy for ulcerative colitis (UC) were above 64.0% at 12 months following treatment initiation. In addition, the 1...

Tool Predicted Vedolizumab Nonresponse in Routine Practice
https://www.staging.medscape.com/viewarticle/940931

Nov 12th, 2020 - Among patients with ulcerative colitis who were treated in routine practice, a point-based clinical scoring tool predicted nonresponse to vedolizumab therapy, according to study findings published online in Clinical Gastroenterology and Hepatology...

Tool Predicted Vedolizumab Nonresponse in Routine Practice
https://www.medscape.com/viewarticle/940931

Nov 12th, 2020 - Among patients with ulcerative colitis who were treated in routine practice, a point-based clinical scoring tool predicted nonresponse to vedolizumab therapy, according to study findings published online in Clinical Gastroenterology and Hepatology...

IBD Immunosuppressives Appears Safe During Pandemic
https://www.staging.medscape.com/viewarticle/940615

Nov 9th, 2020 - (Reuters) - People with inflammatory bowel disease (IBD) do not increase their risk for COVID-19 by taking immunosuppressive drugs to control their symptoms, according to a study of more than 5,300 patients with Crohn's disease or ulcerative colit...

IBD Immunosuppressives Appears Safe During Pandemic
https://www.medscape.com/viewarticle/940615

Nov 9th, 2020 - (Reuters) - People with inflammatory bowel disease (IBD) do not increase their risk for COVID-19 by taking immunosuppressive drugs to control their symptoms, according to a study of more than 5,300 patients with Crohn's disease or ulcerative colit...

see more →

Patient Education  59 results see all →